Barnidipine  | 
|
| AHFS/Drugs.com | International Drug Names | 
|---|
Routes of administration | Oral | 
|---|
| ATC code |  | 
|---|
|
  3-(3R)-1-Benzylpyrrolidin-3-yl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate     | 
| CAS Number |  | 
|---|
| PubChem CID |  | 
|---|
| ChemSpider |  | 
|---|
| UNII |  | 
|---|
| ChEMBL |  | 
|---|
| CompTox Dashboard (EPA) |  | 
|---|
|
| Formula | C27H29N3O6 | 
|---|
| Molar mass | 491.544 g·mol−1 | 
|---|
| 3D model (JSmol) |  | 
|---|
  [O-][N+](=O)c1cccc(c1)[C@H]4C(/C(=O)OC)=C(\N\C(=C4\C(=O)O[C@H]3CCN(Cc2ccccc2)C3)C)C     | 
  InChI=1S/C27H29N3O6/c1-17-23(26(31)35-3)25(20-10-7-11-21(14-20)30(33)34)24(18(2)28-17)27(32)36-22-12-13-29(16-22)15-19-8-5-4-6-9-19/h4-11,14,22,25,28H,12-13,15-16H2,1-3H3/t22-,25-/m0/s1   NKey:VXMOONUMYLCFJD-DHLKQENFSA-N   N    | 
  N Y (what is this?)  (verify) | 
 Barnidipine (INN; also known as mepirodipine) is a calcium channel blocker which belongs to the dihydropyridine (DHP) group of calcium channel blockers. It is used in the treatment of hypertension.[1] 
 Pharmacodynamics
 Barnidipine is a pure S,S isomer, a lipophilic 1,4-dihydropyridine calcium channel blocker, which, like other compounds in the class, shows a high affinity for calcium channels, particularly the L-type slow channels of smooth muscle cells found in the vessel wall.[2] Calcium channel blocking drugs have the characteristic of interfering with the flow of calcium ions into the interior of cells through the slow channels of the plasma membrane. 
 References
   - ^ CID 443869 from PubChem 
  - ^ van Zwieten PA (1998). "Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist". Blood Pressure. Supplement. 1: 5–8. PMID 9660520. 
  
   | 
|---|
| Calcium | | VDCCsTooltip Voltage-dependent calcium channels |  | 
|---|
 
  | 
|---|
| Potassium | | VGKCsTooltip Voltage-gated potassium channels |  | 
|---|
 | IRKsTooltip Inwardly rectifying potassium channel | | Blockers |  | 
|---|
 | Activators |   - GIRKTooltip G protein-coupled inwardly rectifying potassium channel-specific: ML-297 (VU0456810)
     | 
|---|
 
  | 
|---|
 | KCaTooltip Calcium-activated potassium channel |  | 
|---|
 | K2PsTooltip Tandem pore domain potassium channel |  | 
|---|
 
  | 
|---|
| Sodium | | VGSCsTooltip Voltage-gated sodium channels |  | 
|---|
 | ENaCTooltip Epithelial sodium channel |  | 
|---|
 | ASICsTooltip Acid-sensing ion channel |  | 
|---|
 
  | 
|---|
| Chloride | | CaCCsTooltip Calcium-activated chloride channel |  | 
|---|
 | CFTRTooltip Cystic fibrosis transmembrane conductance regulator |  | 
|---|
 | Unsorted |  | 
|---|
 
  | 
|---|
| Others | | TRPsTooltip Transient receptor potential channels |  | 
|---|
 | LGICsTooltip Ligand gated ion channels |  | 
|---|
 
  | 
|---|
See also: Receptor/signaling modulators • Transient receptor potential channel modulators  |